TGFB1 and pulmonary arterial hypertension: Thus, it has long been hypothesized that pathologic TGF-β signaling in PAH and related fibrotic conditions operates through a positive feedback loop of extracellular matrix deposition, increased stiffness, and further TGF-β activation (106, 107).